Beta Bionics Inc.
BBNX | NASDAQ
$16.15
-$0.60 (-3.58%)
Nov 2, 2026, 11:09 AM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 35.51M | 32.01M | 27.63M | 32.12M | 27.25M | 23.24M | 17.64M | 20.44M | 16.71M | 15.05M | 12.93M | 8.35M | 3.09M |
Cost of Revenue | 15.17M | 13.11M | 11.19M | 13.18M | 12.13M | 10.74M | 8.67M | 8.75M | 7.79M | 6.96M | 5.73M | 3.29M | 1.87M |
Gross Profit | 20.33M | 18.9M | 16.44M | 18.94M | 15.12M | 12.5M | 8.97M | 11.69M | 8.91M | 8.08M | 7.2M | 5.06M | 1.23M |
Operating Income | -26.61M | -25.58M | -24.27M | -16.12M | -17.04M | -19.87M | -18.64M | -13.04M | -10.98M | -11.78M | -9.45M | -8.37M | -8.78M |
Interest Income | 2.26M | 2.18M | 2.38M | 2.66M | 2.83M | 3.01M | 2.44M | 951K | 826K | 993K | 1.14M | 1.25M | 393K |
Pretax Income | -24.35M | -23.4M | -21.9M | -13.47M | -14.21M | -16.87M | -28.66M | -18.11M | -9.74M | -14.46M | -12.45M | -18.85M | -8.68M |
Net Income | -24.35M | -23.4M | -21.9M | -13.47M | -14.21M | -16.87M | -28.66M | -18.11M | -9.74M | -14.46M | -12.45M | -18.85M | -8.68M |
Selling & General & Admin | 34.97M | 34.24M | 30.35M | 24.94M | 23.97M | 23.5M | 20.02M | 15.51M | 14.75M | 13.52M | 11.18M | 8.97M | 6.15M |
Research & Development | 11.98M | 10.24M | 10.36M | 10.13M | 8.2M | 8.87M | 7.59M | 9.21M | 5.14M | 6.35M | 5.48M | 4.46M | 3.85M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 46.94M | 44.48M | 40.71M | 35.07M | 32.16M | 32.38M | 27.61M | 24.73M | 19.89M | 19.87M | 16.65M | 13.43M | 10.01M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 25.12M | 24.64M | 20.74M | 16.33M | 16.05M | 15.62M | 13.4M | 10.8M | 9.65M | 8.97M | 7.66M | 5.62M | 3.33M |
Cost & Expenses | 62.11M | 57.59M | 51.9M | 48.25M | 44.3M | 43.11M | 36.28M | 33.48M | 27.68M | 26.83M | 22.39M | 16.72M | 11.88M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 46.54M | 44.55M | 44.44M | 40.53M | 43.63M | 43.39M | 43.12M | 42.86M | 42.86M | 42.86M | 43.35M | 42.86M | 42.86M |
Shares Outstanding (Diluted) | 46.54M | 44.55M | 44.44M | 40.53M | 43.63M | 43.39M | 43.12M | 42.86M | 42.86M | 42.86M | 43.35M | 42.86M | 42.86M |
EPS (Basic) | -0.52 | -0.53 | -0.49 | -0.33 | -0.33 | -0.39 | -0.66 | -0.42 | -0.23 | -0.34 | -0.29 | -0.44 | -0.20 |
EPS (Diluted) | -0.52 | -0.53 | -0.49 | -0.33 | -0.33 | -0.39 | -0.66 | -0.42 | -0.23 | -0.34 | -0.29 | -0.44 | -0.20 |
EBITDA | -26.61M | -24.46M | -20.91M | -12.53M | -13.53M | -16.22M | -28.05M | -17.58M | -9.12M | -13.89M | -11.89M | -18.3M | -8.37M |
EBIT | -26.61M | -25.58M | -21.9M | -13.47M | -14.21M | -16.87M | -28.66M | -18.11M | -9.74M | -14.46M | -12.45M | -18.85M | -8.68M |
Depreciation & Amortization | 1.31M | 1.12M | 987K | 935K | 683K | 653K | 604K | 529K | 615K | 576K | 563K | 544K | 311.33K |
Add to Watchlist
Select watchlists to add or remove BBNX